The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Polley, Mei-Yin
One or more keywords matched the following items that are connected to Polley, Mei-Yin
Item TypeName
Concept Glioblastoma
Academic Article Statistical and practical considerations for clinical evaluation of predictive biomarkers.
Academic Article Impact of bevacizumab chemotherapy on craniotomy wound healing.
Academic Article Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: a phase I study.
Academic Article Evaluation of diffusion parameters as early biomarkers of disease progression in glioblastoma multiforme.
Academic Article Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide.
Academic Article Conditional probability of survival in patients with newly diagnosed glioblastoma.
Academic Article Serial analysis of imaging parameters in patients with newly diagnosed glioblastoma multiforme.
Academic Article Assessment of perfusion MRI-derived parameters in evaluating and predicting response to antiangiogenic therapy in patients with newly diagnosed glioblastoma.
Academic Article An extent of resection threshold for newly diagnosed glioblastomas.
Academic Article Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study.
Academic Article Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM.
Academic Article Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma.
Academic Article Six-month progression-free survival as an alternative primary efficacy endpoint to overall survival in newly diagnosed glioblastoma patients receiving temozolomide.
Academic Article Leveraging external data in the design and analysis of clinical trials in neuro-oncology.
Academic Article NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma.
Search Criteria
  • Glioblastoma